Ironwood Pharmaceuticals
Yahoo Finance • 11 months ago
Ironwood Pharmaceuticals Maintains FY 2023 Financial Guidance and Announces FY 2024 Financial Guidance
– Expects high-single digit percentage LINZESS® EUTRx prescription demand growth in 2024 – – Expects 2024 adjusted EBITDA of greater than $150 million – BOSTON, January 08, 2024--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (Nasdaq: I... Full story
Yahoo Finance • 11 months ago
Ironwood Announces the Completion of Squeeze-Out Merger With VectivBio
BOSTON, December 12, 2023--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. ("Ironwood") (Nasdaq: IRWD), a GI-focused healthcare company, today announced the successful completion of the squeeze-out merger under Swiss law (the "Squeeze-Out... Full story
Yahoo Finance • 2 years ago
15 Small Innovative Companies According to the Media
In this piece, we will take a look at the fifteen small innovative companies according to the media. For more small and innovative companies, head on over to 5 Small Innovative Companies According to the Media. Innovation is the bedrock o... Full story
Yahoo Finance • 2 years ago
12 Most Undervalued Pharma Stocks To Buy According To Hedge Funds
In this article, we discuss 12 most undervalued pharma stocks to buy according to hedge funds. If you want to see more stocks in this selection, check out 5 Most Undervalued Pharma Stocks To Buy According To Hedge Funds. Fitch Ratings has... Full story
Yahoo Finance • 2 years ago
Ironwood Pharmaceuticals Provides Update on FY 2022 Financial Guidance and Announces FY 2023 Financial Guidance
– sNDA submitted to U.S. FDA in December 2022 seeking approval of a new indication of LINZESS® (linaclotide) for functional constipation in children and adolescents 6 to 17 years of age – – Expects high single-digit LINZESS® EUTRx prescri... Full story
Yahoo Finance • 2 years ago
Ironwood Pharmaceuticals to Present at the 41st Annual J.P. Morgan Healthcare Conference
BOSTON, January 04, 2023--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a GI-focused healthcare company, today announced that Tom McCourt, CEO, will present at the 41st Annual J.P. Morgan Healthcare Conference on Wednesda... Full story
Yahoo Finance • 2 years ago
Keurig Dr Pepper, VICI Properties and ON Semiconductor Set to Join S&P 500; Others to Join S&P MidCap 400, and S&P SmallCap 600
NEW YORK, June 3, 2022 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 500, S&P MidCap 400 and S&P SmallCap 600 indices: VICI Properties Inc. (NYSE:VICI) will replace Cerner Corp. (NASD: CERN)... Full story
